Epiduo 0,1 %/2,5 % Gel 瑞典 - 英文 - Läkemedelsverket (Medical Products Agency)

epiduo 0,1 %/2,5 % gel

Epiduo 0,1 %/2,5 % Gel 瑞典 - 英文 - Läkemedelsverket (Medical Products Agency)

epiduo 0,1 %/2,5 % gel

Epiduo 0,1 %/2,5 % Gel 瑞典 - 英文 - Läkemedelsverket (Medical Products Agency)

epiduo 0,1 %/2,5 % gel

Epiduo 0,1 %/2,5 % Gel 瑞典 - 英文 - Läkemedelsverket (Medical Products Agency)

epiduo 0,1 %/2,5 % gel

Epiduo 0,1 %/2,5 % Gel 瑞典 - 英文 - Läkemedelsverket (Medical Products Agency)

epiduo 0,1 %/2,5 % gel

Epiduo 0,1 %/2,5 % Gel 瑞典 - 英文 - Läkemedelsverket (Medical Products Agency)

epiduo 0,1 %/2,5 % gel

Epiduo 0,1 %/2,5 % Gel 瑞典 - 英文 - Läkemedelsverket (Medical Products Agency)

epiduo 0,1 %/2,5 % gel

Epiduo 0,1 %/2,5 % Gel 瑞典 - 英文 - Läkemedelsverket (Medical Products Agency)

epiduo 0,1 %/2,5 % gel

EPIDUO FORTE adapalene/benzoyl peroxide 0.3%/2.5% gel tube 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

epiduo forte adapalene/benzoyl peroxide 0.3%/2.5% gel tube

galderma australia pty ltd - adapalene, quantity: 3 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: docusate sodium; disodium edetate; poloxamer; propylene glycol; purified water; glycerol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris, when comedones, numerous papules and pustules are present in patients 12 years of age and older and the condition has not responded to first line treatment (see clinical trials).

EPIDUO FORTE adapalene/benzoyl peroxide 0.3%/2.5% gel bottle 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

epiduo forte adapalene/benzoyl peroxide 0.3%/2.5% gel bottle

galderma australia pty ltd - adapalene, quantity: 3 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: docusate sodium; disodium edetate; poloxamer; propylene glycol; purified water; glycerol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris, when comedones, numerous papules and pustules are present in patients 12 years of age and older and the condition has not responded to first line treatment (see clinical trials).